SWOG clinical trial number
SWOG-9158
Evaluation of Trans Retinoic Acid and Alpha Interferon In Patients with Squamous Cell Carcinoma of the Lung (Stage IV)
Closed
Phase
Accrual
41%
Abbreviated Title
Evaluation of Trans Retinoic Acid and Alpha Interferon In Patients with Squamous Cell Carcinoma of the Lung (Stage IV)
Activated
01/01/1993
Closed
05/01/1996
Research committees
Lung Cancer
Other Clinical Trials
SWOG Clinical Trial Number
S2414
INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
1%
Open
Phase
SWOG Clinical Trial Number
A082002
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007
RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open